HomeFocus → The Drug Industry's Triumph Over the DEA

The Drug Industry's Triumph Over the DEA Print E-mail
Written by FHI's Week in Review   
Monday, 16 October 2017 17:57

opioid-drugs-medicare Scott Higham and Lenny Bernstein report on Oct. 15, 2017:

Amid a targeted lobbying effort, Congress weakened the DEA's ability to go after drug distributors, even as opioid-related deaths continued to rise, a Washington Post and 60 Minutes investigation finds.

Read more in the current issue of Week in Review>>
Last Updated on Tuesday, 07 November 2017 20:07

Website design, development, and hosting provided by